Eterna Therapeutics Inc. (ERNA)
NASDAQ · Healthcare
Eterna Therapeutics Inc. Operating Income 2010–2024
Eterna Therapeutics Inc. annual/quarterly operating income history and growth rate from 2010 to 2024. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- Eterna Therapeutics Inc. operating income for the quarter ending September 30, 2024 was -2.3 M, a 58.96% decrease year-over-year.
- Eterna Therapeutics Inc. operating income for the twelve months ending September 30, 2024 was -18.5 M, a 4.73% increase year-over-year.
- Eterna Therapeutics Inc. annual operating income for 2024 was -15.7 M, a 25.84% decrease from 2023.
- Eterna Therapeutics Inc. annual operating income for 2023 was -21.1 M, a 36.37% decrease from 2022.
- Eterna Therapeutics Inc. annual operating income for 2022 was -33.2 M, a 358.29% increase from 2020.
- Eterna Therapeutics Inc. annual operating income for 2020 was -7.2 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Eterna Therapeutics Inc. Operating Income — FAQ
Eterna Therapeutics Inc. (ERNA) operating income over the last 14 years — annual and quarterly figures with year-over-year growth and charts.
What is Eterna Therapeutics Inc.'s operating income?
Eterna Therapeutics Inc. (ERNA) reported operating income of -$16M for fiscal 2024.
Where can I see ERNA's operating income history?
The chart and table above show Eterna Therapeutics Inc.'s operating income by year and by quarter, including the growth rate.